Method of treating cancer with combinations of histone deacetylase inhibitors (HDAC1… Grant US-11890269-B2 United States of America 06 Feb 2024
Compositions, methods, systems and/or kits for preventing and/or treating neoplasms Grant US-11890292-B2 United States of America 06 Feb 2024
Long-acting VEGF inhibitors for intraocular neovascularization Grant US-11576948-B2 United States of America 14 Feb 2023
Methods and compositions for treatment of angiogenic disorders using anti-VEGF agents Grant US-11524053-B2 United States of America 13 Dec 2022
Long-acting VEGF inhibitors for intraocular neovascularization Grant US-11433118-B2 United States of America 06 Sep 2022
Long-acting VEGF inhibitors for intraocular neovascularization Grant US-11382955-B2 United States of America 12 Jul 2022
Compositions, methods, systems and/or kits for preventing and/or treating neoplasms Grant US-11369585-B2 United States of America 28 Jun 2022
Method of treating cancer with combinations of histone deacetylase inhibitors (HDAC1… Grant US-10966957-B2 United States of America 06 Apr 2021
Method of treating cancer with combinations of histone deacetylase inhibitors (HDAC1… Grant US-10016392-B2 United States of America 10 Jul 2018
TENASCIN-W AND BILIARY TRACT CANCERS Application WO-2017072669-A1 World Intellectual Property Organisation (WIPO) 04 May 2017
Compositions for treating cancer with combinations of histone deacetylase inhibitors (HDAC1… Grant US-9364500-B2 United States of America 14 Jun 2016
Inhibition of neovascularization by simultaneous inhibition of prostanoid IP and EP4… Grant US-9295665-B2 United States of America 29 Mar 2016
Methods of inhibiting vascular endothelial growth factor activity Grant US-9273113-B2 United States of America 01 Mar 2016
Chitosan-alginate scaffold cell culture system and related methods Grant US-9157908-B2 United States of America 13 Oct 2015
Human monoclonal antibody neutralizing vascular endothelial growth factor receptor and… Grant US-9150650-B2 United States of America 06 Oct 2015
Method of treating cancer with combinations of histone deacetylase inhibitors (HDAC1… Grant US-8933078-B2 United States of America 13 Jan 2015
Phenoxypyridine derivative salts and crystals thereof, and process for preparing the same Grant US-8377938-B2 United States of America 19 Feb 2013
Pyridine derivatives and pyrimidine derivatives (3) Grant US-8288538-B2 United States of America 16 Oct 2012
Inhibitors of vascular endothelial growth factor activity Grant US-8273353-B2 United States of America 25 Sep 2012
Methods for using inhibitors of vascular endothelial growth factor activity Grant US-8268313-B2 United States of America 18 Sep 2012
Cell free methods for detecting protein-ligand binding Grant US-8241860-B2 United States of America 14 Aug 2012
Methods for the modulation of neovascularization and/or the growth of collateral arteries… Grant US-8101188-B2 United States of America 24 Jan 2012
SMOC1, TENASCIN-C AND BRAIN CANCERS Application WO-2011107586-A1 World Intellectual Property Organisation (WIPO) 09 Sep 2011
Pharmaceutical composition for treating esophageal cancer Grant US-7998948-B2 United States of America 16 Aug 2011
Substituted pyridines and pyridazines with angiogenesis inhibiting activity Grant US-7977333-B2 United States of America 12 Jul 2011
Cell line comprising vector encoding truncated FLK-1 receptor Grant US-7964399-B2 United States of America 21 Jun 2011
SPLEEN TYROSINE KINASE AND BRAIN CANCERS Application WO-2011045352-A2 World Intellectual Property Organisation (WIPO) 21 Apr 2011
Process for preparing phenoxypyridine derivatives Grant US-7790885-B2 United States of America 07 Sep 2010
Combination comprising a vasculostatic compound and an alkylating agent for the treatment… Grant US-7754716-B2 United States of America 13 Jul 2010
Therapeutic method for reducing angiogenesis Grant US-7740841-B1 United States of America 22 Jun 2010
AAV vector compositions and methods for enhanced expression of immunoglobulins using the… Grant US-7714119-B2 United States of America 11 May 2010
Compositions and methods for enhanced expression of recombinant polypeptides from a… Grant US-7709224-B2 United States of America 04 May 2010
Combined methods for tumor coagulation and tumor treatment Grant US-7691380-B2 United States of America 06 Apr 2010
Compositions and methods for enhanced expression of recombinant polypeptides from a… Grant US-7662623-B2 United States of America 16 Feb 2010
Methods to express recombinant proteins from lentiviral vectors Grant US-7632509-B2 United States of America 15 Dec 2009
Anti-human VEGF receptor Flt-1 monoclonal antibody Grant US-7615215-B2 United States of America 10 Nov 2009
Anti-human VEGF receptor Flt-1 monoclonal antibody Grant US-7615214-B2 United States of America 10 Nov 2009
Antibodies that bind to pleiotrophin growth factor receptor Grant US-7608264-B2 United States of America 27 Oct 2009
Pleiotrophin growth factor receptor for the treatment of proliferative, vascular and… Grant US-7528109-B2 United States of America 05 May 2009
Methods for the modulation of neovascularization and/or the growth of collateral arteries… Grant US-7507705-B2 United States of America 24 Mar 2009
Angiogenesis inhibiting 5-substituted-1,2,4-thiadiazolyl derivatives Grant US-7208503-B2 United States of America 24 Apr 2007
Methods and compositions for screening for angiogenesis modulating compounds Grant US-7196190-B2 United States of America 27 Mar 2007
Combined methods and compositions for tumor vasculature targeting and tumor treatment Grant US-7112317-B2 United States of America 26 Sep 2006
Anti-human VEGF receptor FLT-1 monoclonal antibody Grant US-7052693-B2 United States of America 30 May 2006
Anti-human VEGF receptor Flt-1 monoclonal antibody Grant US-6986890-B1 United States of America 17 Jan 2006
Methods and compositions for screening for angiogenesis modulating compounds Grant US-6867348-B1 United States of America 15 Mar 2005
Method and reagent for the treatment of diseases or conditions related to levels of… Grant US-6818447-B1 United States of America 16 Nov 2004
Combined methods and compositions for coagulation and tumor treatment Grant US-6749853-B1 United States of America 15 Jun 2004
Formulations for hydrophobic pharmaceutical agents Grant US-6696482-B2 United States of America 24 Feb 2004
Substituted pyridines and pyridazines with angiogenesis inhibiting activity Grant US-6689883-B1 United States of America 10 Feb 2004
Crystals of the tyrosine kinase domain of non-insulin receptor tyrosine kinases Grant US-6682921-B1 United States of America 27 Jan 2004
Methods of modulating protein tyrosine kinase function with substituted indolinone… Grant US-6680335-B2 United States of America 20 Jan 2004
3-(4-amidopyrrol-2-ylmethylidene)-2-indolinone derivatives as protein kinase inhibitors Grant US-6653308-B2 United States of America 25 Nov 2003
Heteroarylcarboxamide compounds active against protein tyrosine kinase related disorders Grant US-6649635-B2 United States of America 18 Nov 2003
Process and device for making gratings in optical fibres Grant US-6647179-B2 United States of America 11 Nov 2003
3-[4-Substituted heterocyclyl)-pyrrol-2-ylmethylidene]-2- indolinone derivatives as… Grant US-6642232-B2 United States of America 04 Nov 2003
Adenovirus-mediated intratumoral delivery of an angiogenesis antagonist for the treatment… Grant US-6638502-B1 United States of America 28 Oct 2003
Anti-human VEGF receptor Flt-1 monoclonal antibody Grant US-6617160-B1 United States of America 09 Sep 2003
Angiogenesis inhibiting thiadiazolyl pyridazine derivatives Grant US-6602873-B2 United States of America 05 Aug 2003
Methods for the modulation of the growth of collateral arteries and/or other arteries… Grant US-6592862-B1 United States of America 15 Jul 2003
Pyrrole substituted 2-indolinone protein kinase inhibitors Grant US-6573293-B2 United States of America 03 Jun 2003
Methods of modulating tyrosine protein kinase function with indolinone compounds Grant US-6514981-B1 United States of America 04 Feb 2003
VEGF-gelonin for targeting the vasculature of solid tumors Grant US-6451312-B1 United States of America 17 Sep 2002
Treatment of platelet derived growth factor related disorders such as cancers Grant US-6331555-B1 United States of America 18 Dec 2001
Isoxazole-4-carboxamide compounds active against protein tryosine kinase related disorders Grant US-6316479-B1 United States of America 13 Nov 2001
Formulations for hydrophobic pharmaceutical agents Grant US-6248771-B1 United States of America 19 Jun 2001
Methods and compositions for the specific coagulation of vasculature Grant US-6093399-A United States of America 25 Jul 2000
Compositions for targeting the vasculature of solid tumors Grant US-6051230-A United States of America 18 Apr 2000
Kits and methods for the specific coagulation of vasculature Grant US-6036955-A United States of America 14 Mar 2000
Methods for the specific coagulation of vasculature Grant US-6004555-A United States of America 21 Dec 1999
Methods for targeting the vasculature of solid tumors Grant US-6004554-A United States of America 21 Dec 1999
Treatment of platelet derived growth factor related disorders such as cancers Grant US-5990141-A United States of America 23 Nov 1999
Methods and compositions for targeting the vasculature of solid tumors Grant US-5965132-A United States of America 12 Oct 1999
Treatment of platelet derived growth factor related disorders such as cancers Grant US-5958959-A United States of America 28 Sep 1999
Method for molecular diagnosis of tumor angiogenesis and metastasis Grant US-5942385-A United States of America 24 Aug 1999
Treatment of platelet derived growth factor related disorders such as cancers Grant US-5932602-A United States of America 03 Aug 1999
Compounds and methods for inhibiting hyper-proliferative cell growth Grant US-5914343-A United States of America 22 Jun 1999
Tissue factor compositions and ligands for the specific coagulation of vasculature Grant US-5877289-A United States of America 02 Mar 1999
Compositions for targeting the vasculature of solid tumors Grant US-5863538-A United States of America 26 Jan 1999
Methods for treating the vasculature of solid tumors Grant US-5855866-A United States of America 05 Jan 1999
Analogs for specific oligosaccharide-protein interactions and uses therefor Grant US-5795860-A United States of America 18 Aug 1998
Methods for targeting the vasculature of solid tumors Grant US-5776427-A United States of America 07 Jul 1998
Compounds and methods for inhibiting hyper-proliferative cell growth Grant US-5760066-A United States of America 02 Jun 1998
Compounds and methods for inhibiting hyper-proliferative cell growth Grant US-5721277-A United States of America 24 Feb 1998
Treatment of platelet derived growth factor related disorders such as cancers Grant US-5700822-A United States of America 23 Dec 1997
Induction of vascular endothelial growth factor (VEGF) by transition metals Grant US-5480975-A United States of America 02 Jan 1996